$38.05
$0.29
(0.77%)
Quote as of 4:00 PM EST on 02/09/12
BioMarin Pharmaceutical
NASDAQ:BMRN
|
$38.05
|
|
| Today's Open | $37.75 |
|---|---|
| Previous Close | $37.76 |
| Daily Range | $37.67 - $38.32 |
| 52-Week Range | $23.09 - $38.66 |
| Market Cap | $4.35B |
| P/E Ratio | -151.04 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,743,043 |
| Average Daily Volume | 986,679 |
| Current FY EPS | -$0.34 |
BMRN Information
| Description |
|---|
| The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings
Qiagen Expands with New Deals - Analyst Blog
JPMorgan Confab Kicks Off Biotech 2012
Too Early for a New Biotech Orphan?
BioMarin's Facility Expansion Backed - Analyst Blog
Pipeline Progress at BioMarin - Analyst Blog
Facility Expansion at BioMarin - Analyst Blog
Should You Get Out of BioMarin Pharmaceutical Before Next Quarter?
